Related Experiment Video
Updated: May 24, 2026
11:29
HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells
Published on: July 20, 2016
Predicting survival in chronic lymphocytic leukemia.
Ali Bazargan1, Constantine S Tam, Michael J Keating
1Hematology Department, St Vincent's Hospital, Melbourne, VIC, Australia.
Expert Review of Anticancer Therapy
|February 29, 2012
Summary
Predicting survival in early chronic lymphocytic leukemia (CLL) benefits from combining prognostic markers. Integrating traditional and novel factors into models offers the most complete patient information for clinical guidance.
Area of Science:
- Hematology
- Oncology
- Molecular Biology
Background:
- Chronic lymphocytic leukemia (CLL) is a common B-cell malignancy.
- Accurate prognostic markers are crucial for guiding treatment decisions in early-stage CLL.
- Current prognostic tools have limitations in predicting patient outcomes comprehensively.
Purpose of the Study:
- To review current prognostic factors for chronic lymphocytic leukemia (CLL).
- To discuss the application of these factors in clinical practice.
- To highlight the benefit of combining prognostic markers for improved survival prediction.
Main Methods:
- Review of traditional prognostic factors (clinical staging, lymphocyte doubling time, β2-microglobulin/thymidine kinase).
- Evaluation of novel prognostic markers (karyotypic aberrations via FISH or CpG oligonucleotide karyotyping, IgVH mutation status).
- Discussion of prognostic normograms and models integrating multiple factors.
Main Results:
- Individual prognostic factors show significant correlations with survival in CLL.
- Combining multiple prognostic markers provides more complete prognostic information than single factors.
- Prognostic models and normograms offer a comprehensive approach to patient assessment.
Conclusions:
- A combination of prognostic factors is superior for predicting survival in early-stage CLL.
- Integrating traditional and novel markers into models enhances clinical management strategies.
- Further application of prognostic models in clinical settings is recommended for personalized patient care.
More Related Videos
Related Concept Videos
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
01:15Assumptions of Survival Analysis
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.